Literature DB >> 26410631

Risk factors for postoperative anxiety and depression after surgical treatment for lung cancer†.

Samina Park1, Chang Hyun Kang2, Yoohwa Hwang1, Yong Won Seong3, Hyun Joo Lee1, In Kyu Park1, Young Tae Kim1.   

Abstract

OBJECTIVES: Psychological distress associated with cancer treatment is an emerging issue in the management of cancer patients. The aim of this study was to identify the prevalence of postoperative anxiety and depression after surgical treatment for lung cancer, and to assess the risk factors associated with these phenomena.
METHODS: Patients who underwent curative surgical resection for primary lung cancer were included in this study. Patients with complex treatment histories (recurrent or metastatic lung cancer or neoadjuvant treatment) and those taking psychiatric medication were excluded. We prospectively evaluated the degrees of pre- and postoperative anxiety and depression using a Hospital Anxiety Depression Scale questionnaire. The relationships between clinical and patient factors and anxiety and depression after surgical treatment for lung cancer were assessed.
RESULTS: A total of 278 patients were enrolled. The mean age was 62 years. Thoracoscopic resection was performed in 246 patients (89%). The prevalence rates of preoperative anxiety and depression were 8% (n = 22) and 12% (n = 32), and changed to 9% (n = 26) and 19% (n = 54) postoperatively (P = 0.37 and <0.001, respectively). Gender, age, marital status, advanced clinical stage, alcohol abuse, smoking status, length of hospital stay, pulmonary function and preoperative comorbidities were not associated with postoperative anxiety and depression. Multivariate analysis revealed that thoracotomy was a risk factor for postoperative anxiety after adjusting for preoperative anxiety (odds ratio [OR] = 4.5, P = 0.002). Thoracotomy (OR = 3.4, P = 0.009), postoperative dyspnoea (OR = 4.8, P < 0.001), severe pain (OR = 3.9, P = 0.001) and diabetes mellitus (OR = 3.0, P = 0.012) were identified as risk factors for postoperative depression after adjusting for preoperative depression. Twenty-four patients were referred to mental health professionals and provided with supportive psychotherapy or pharmacological intervention. Of these, 14 patients (56%) were diagnosed with an adjustment disorder.
CONCLUSIONS: Postoperative psychological distress and, in particular, depression increased after surgical treatment for lung cancer. Postoperative anxiety and depression were aggravated by residual symptoms after surgery. Careful psychological evaluation and appropriate management are required to improve patients' quality of life after lung cancer surgery.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Lung neoplasms; Mental health; Postoperative care; Thoracic surgery

Mesh:

Year:  2015        PMID: 26410631     DOI: 10.1093/ejcts/ezv336

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  23 in total

1.  Longitudinal Assessment of Prevalence and Risk Factors of Anxiety and Depression among Prostate Cancer Survivors Post-Resection.

Authors:  Ruibin Yu; Haibo Li
Journal:  Psychiatr Q       Date:  2021-01-06

2.  The impact of resection method and patient factors on quality of life among stage IA non-small cell lung cancer surgical patients.

Authors:  Rebecca M Schwartz; Rowena Yip; Raja M Flores; Ingram Olkin; Emanuela Taioli; Claudia Henschke
Journal:  J Surg Oncol       Date:  2016-10-28       Impact factor: 3.454

3.  Thoracic surgeon and patient focus groups on decision-making in early-stage lung cancer surgery.

Authors:  Rebecca M Schwartz; Ksenia Gorbenko; Samantha M Kerath; Raja Flores; Sheila Ross; Tonya N Taylor; Emanuela Taioli; Claudia Henschke
Journal:  Future Oncol       Date:  2017-12-12       Impact factor: 3.404

4.  Prospective evaluation of anxiety, depression and quality of life in medically inoperable early stage non-small cell lung cancer patients treated with stereotactic ablative radiotherapy.

Authors:  Jacek Rutkowski; Magdalena Szymanik; Maciej Blok; Joanna Kozaka; Renata Zaucha
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-21

5.  Intraoperative ketamine for prevention of depressive symptoms after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial.

Authors:  G A Mashour; A Ben Abdallah; K O Pryor; R El-Gabalawy; P E Vlisides; E Jacobsohn; E Lenze; H R Maybrier; R A Veselis; M S Avidan
Journal:  Br J Anaesth       Date:  2018-09-19       Impact factor: 9.166

6.  Efficacy of 50 mg pregabalin for prevention of postoperative neuropathic pain after video-assisted thoracoscopic surgery and thoracotomy: a 3-month prospective randomized controlled trial.

Authors:  Takahiro Homma; Yoshinori Doki; Yutaka Yamamoto; Toshihiro Ojima; Yoshifumi Shimada; Naoya Kitamura; Yushi Akemoto; Yuki Hida; Naoki Yoshimura
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

7.  Incidence and features of preoperative anxiety in patients undergoing elective non-cardiac surgery.

Authors:  Vilma Kuzminskaitė; Justina Kaklauskaitė; Justė Petkevičiūtė
Journal:  Acta Med Litu       Date:  2019

8.  Changes in quality of life after surgery or radiotherapy in early-stage lung cancer.

Authors:  Rebecca M Schwartz; Naomi Alpert; Kenneth Rosenzweig; Raja Flores; Emanuela Taioli
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

9.  Is nutritional status associated with the level of anxiety, depression and pain in patients with lung cancer?

Authors:  Mariusz Chabowski; Jacek Polański; Beata Jankowska-Polańska; Dariusz Janczak; Joanna Rosińczuk
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

10.  Surgery, stomas, and anxiety and depression in inflammatory bowel disease: a retrospective cohort analysis of privately insured patients.

Authors:  L A Sceats; M S Dehghan; K K Rumer; A Trickey; A M Morris; C Kin
Journal:  Colorectal Dis       Date:  2019-12-05       Impact factor: 3.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.